Introduction Introduction
The incidence of complete Achilles tendon rupture is 18 per 100 000 patient-years 1 and is usually diagnosed clinically by GPs. The extent of clinical misdiagnosis is unknown in Norway, but may be high. 2 This is important as delayed treatment has unfavourable consequences. 1, 3 We report how a GP, with no clinical ultrasound experience, recorded images with a pocket-sized ultrasound device (PSUD) under supervision to confirm a complete Achilles tendon rupture. This could present a new indication for GP ultrasound.
Case report
A 36-year-old man experienced acute pain above the right heel accompanied by an audible snap while sprinting. He immediately had difficulty walking and 3 hours later consulted an on-call GP. Posterior ankle swelling with a tender depression 3 cm proximal to the calcaneum was found. Active plantar flexion against resistance was weak and Simmonds-Thompson test was 'partially positive' on applying a strong calf-squeeze. Based on these findings, calf muscle rupture was diagnosed as the Achilles tendon was thought to be intact. The patient was advised to elevate the foot and wait 2 weeks for improvement. Two days later a second GP, who was aware of a history of an audible snap, considered complete tendon rupture and reexamined the patient. Findings included an absent right heel raise due to weakness, minimal active plantar flexion against gravity and lying prone, significant right ankle swelling without bruising, and an altered angle of declination. Palpation elicited no ankle bony tenderness, yet a painful gap was identified 6 cm proximal from the calcaneal attachment, along the line of the Achilles tendon. Simmonds-Thompson's test was clearly positive. The positive Simmond's triad indicated a clinical diagnosis of complete rupture of the Achilles tendon. A 3.4-8 MHz linear array probe PSUD (VScanÔ dual probe, GE Healthcare), set at a depth of 3.5 cm, was used under the supervision of a rheumatologist experienced in ultrasound. The tendon was enlarged from 1 cm to 6 cm above the calcaneal insertion, where a clear gap was seen ( Figure 1) . Two hours later a radiologist-performed ultrasound (LOGIQ E9Ô, GE Healthcare) and reported an enlarged distal tendon and a complete rupture at 5-6 cm from the calcaneal attachment, creating a 2.7 cm blood-filled gap ( Figure 2 ). Surgical exploration 8 days post-injury found a complete Achilles tendon rupture '5-10 cm above the ankle joint'.
Discussion
Tromsø Hospital serves a large area with a population of approximately 160 000. Between 2010-2014 an average of 21 patients per year were referred by their GP for suspected Achilles rupture. 
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Introduction
Last summer our small medical team visited the Calais 'Jungle'. Since that time much has changed and the camp is being demolished and by the time this article is read, it will probably be long gone. Some youngsters are finally being brought to the UK under the 'Dubs' amendment. However, once this camp is cleared it will not solve the ongoing flight of refugees from war torn areas: other camps are already appearing.
July 2016
A young Afghan man caught his finger on a sharp point while trying to cross a barbed wire fence. The finger was partially degloved. He attended the local hospital, where they placed a few sutures, but now, 2 weeks later, the skin is necrotic and the underlying tissue looks infected. He is in danger of losing his finger. A middle-aged Sudanese man has been having rigors and is generally unwell. He says it is similar to when he last had malaria.
A young Ukrainian woman complains of lower back pain and urinary frequency. The paths of these three people may never have crossed; yet here they are, denizens of the Calais Jungle. They turn up to a makeshift primary care 'clinic' that we set up in the heart of the unofficial refugee camp one weekend in July 2016.
With only basic medical supplies, we are immediately challenged by what we see. How can we arrange secondary care for the young Afghan in danger of losing his finger? We try to persuade him to return to the original local hospital, but he is reluctant. It was not a good experience for him the first time round.
With the other two patients, it is easier. They can attend the Salam clinic run by a local association during weekdays. Later, we receive word that malaria has been confirmed in our Sudanese patient.
More people arrive, presenting with scabies, rat bites, tinea, chest infections, and wheezing from inhaling smoke from fires lit to cook and keep warm in their tents at night. We examine a severely malnourished 2-year-old boy. We meet several of the camp's 600 unaccompanied children, at grave risk of sexual exploitation. We learn that there is inadequate safeguarding in place to protect them. A young Eritrean man comes in worried about his eye. He has sustained direct ocular trauma from a rubber bullet, and will never see normally again out of that eye. We see haematomas from police batons, and hear about children being exposed to tear gas again and again (Figure 1) .
The reality
These are no ordinary patients. They have travelled far from home to escape war, poverty, and misery. They have endured personal odysseys to get here, experienced untold hardships, and suffered unimaginable privations. Many have survived the loss of their families, torture, and rape. Their journeys over, for the moment at least, they must make their homes in the Calais Jungle. Their new shelters are in many cases mere tarpaulin covers, and their new beds just rugs on the ground. They own next to nothing. There is little for them to do, besides use their ingenuity to cross the English Channel in search of a better life. They are vulnerable to exploitation, crime, injury, and disease. Potentially violent clashes with local police, with other ethnic groups resident in the Jungle, or local far health care in a cost effective way. Research shows that half of the population spend very little on health care, while 5% of the population spends almost half of the total amount. 13 Individuals within the top 5% spend about 17 times as much as those individuals within the bottom 50% of healthcare spenders. 13 Higher spenders were identified among the older generation with a higher proportion of multiple expensive chronic conditions. 13 For example, in one area of New Jersey, 1% of the population accounts for one-third of healthcare expenditure.
14 The highest expense for insurers for one patient in that area was US$3.5 million.
14 It is possible that the advanced APMs would offer a valuebased model that enables family physicians to care for their population of patients with substantial primary care needs. This autonomy in care decisions could be a valuable avenue to attract new physicians into family medicine, as reimbursement could be evened out across the spectrum of practice.
Outside of MACRA, innovative models of financing that embrace capitation payments are already beginning to take hold in the healthcare space, and US family physicians can learn from them. An example can be seen in the model of care provided by Iora Health. Iora is a primary care organisation which offers valuable care to populations of patients with chronic conditions. 15 A key aspect of Iora's model is a form of 'capitation' payment, simplifying the process of reimbursement. 15 Iora hires healthcare coaches and institutes home visits as a means to improve care coordination. 15 The positive health outcomes in its patient population are a testament to its innovative model of care delivery.
15
For all the potential for MACRA to make a difference in the current US healthcare system, it is imperfect. MIPS is designed to effectively identify winners and losers each year, irrespective of how much achievement has been made beyond stated thresholds. 7, 8, 16 In addition to this, it is observed that there is a potential for incomes to plateau in future years. 7 Over time, it is intended that, through MACRA, providers would make a shift from MIPS to the advanced APMs, which could offer greater income potential and higher financial risk for healthcare outcomes. 9, 16 There are also other contributory factors to US healthcare spending, and it will take much more than MACRA to make a real impact. For example, managing the complexity of an aging population and medical price inflation would require nuanced health policy formulation in addition to provider reimbursement reform. MACRA creates a crucial opportunity for the US health system to move from a volume-based reimbursement of physicians to a value-based one. A lot could be learnt from the UK experience with initiatives such as the Quality and Outcomes Framework, and the Royal College of General Practitioners International and Overseas Network could play a vital role in forming collaborations for this purpose.
Box 2. MIPS adjustments sliding scale

